Case Consult: Current Standards and Emerging Directions in BRAF-Mutant mCRC Care

ReachMD CME
24/07/2025 5 min

Listen "Case Consult: Current Standards and Emerging Directions in BRAF-Mutant mCRC Care "

Descargar episodio Ver en sitio original

Episode Synopsis

CME credits: 1.00
Valid until: 02-12-2026
Claim your CME credit at https://reachmd.com/programs/cme/case-consult-current-standards-and-emerging-directions-in-braf-mutant-mcrc-care/36508/



This series provides expert perspectives on the management of metastatic colorectal cancer (mCRC), with a focus on the timing and methodology of molecular testing, targeted treatment combinations for BRAF-mutant mCRC, and the management of treatment-related adverse events.

More episodes of the podcast ReachMD CME

When Topicals Fail: The New IPC Consensus Every Clinician Should Know 22/12/2025
Hepatic Encephalopathy: More Common Than You Think 11/12/2025
A Clear Horizon in Plaque Psoriasis: An Update on Investigational Oral Therapies 26/11/2025
The Fifth Pillar? Closing the Gap in HFrEF 14/11/2025
Navigating the Therapeutic Landscape of Platinum-Resistant Ovarian Cancer 14/11/2025
MOA: CDH6-Targeted Antibody-Drug Conjugates 14/11/2025
Clinical Evidence: Insights From Early Trials of CDH6-Targeted Therapies 14/11/2025
Safety and Tolerability of CDH6-Directed Antibody-Drug Conjugates 14/11/2025
Looking Ahead: Integrating CDH6-Targeted Therapies Into Ovarian Cancer Treatment Paradigms 14/11/2025
Advancing gMG Clinical Decisions: Diagnosing Early, Treating Smarter, and Caring Holistically – A Case-Based Treatment Approach 13/11/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA